One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The link between blood pressure and Alzheimer's disease
CharlesDeCarlia
doi : 10.1016/S1474-4422(21)00340-9
Volume 20, Issue 11, November 2021, Pages 878-879
Preserving brain health after intracerebral haemorrhage
JonathanRosandabc
doi : 10.1016/S1474-4422(21)00339-2
Volume 20, Issue 11, November 2021, Pages 879-880
Mesenchymal stem cells for multiple sclerosis: hype or hope?
ReinhardHohlfeldab
doi : 10.1016/S1474-4422(21)00324-0
Volume 20, Issue 11, November 2021, Pages 881-882
Malformations of cortical development as models of altered brain excitability
AndreasSchulze-Bonhagea
doi : 10.1016/S1474-4422(21)00342-2
Volume 20, Issue 11, November 2021, Pages 882-883
The Lancet Neurology's 20th anniversary essay competition
ElenaBecker-BarrosoaLauraHartaHeatherBrownaSarahPasseya
doi : 10.1016/S1474-4422(21)00336-7
Volume 20, Issue 11, November 2021, Page 884
Advancing neuropalliative care
Benzi MKlugeraTimothy EQuillb
doi : 10.1016/S1474-4422(21)00326-4
Volume 20, Issue 11, November 2021, Page 885
Advancing neuropalliative care
Rajinder KDhamijaaAlveeSalujaaJanisMiyasakib
doi : 10.1016/S1474-4422(21)00333-1
Volume 20, Issue 11, November 2021, Pages 885-886
Advancing neuropalliative care
Nathan AShlobinadMarkBernsteinbc
doi : 10.1016/S1474-4422(21)00328-8
Volume 20, Issue 11, November 2021, Page 886
Advancing neuropalliative care
MilenaGandyaLouiseSharpeb
doi : 10.1016/S1474-4422(21)00329-X
Volume 20, Issue 11, November 2021, Page 887
Multiple sclerosis meets systems immunology
ReinhardHohlfeldab
doi : 10.1016/S1474-4422(21)00325-2
Volume 20, Issue 11, November 2021, Pages 887-888
Multiple sclerosis meets systems immunology – Authors' reply
AmitBar-OraRuiLia
doi : 10.1016/S1474-4422(21)00327-6
Volume 20, Issue 11, November 2021, Page 888
Marie Vidailhet: recognising the importance of teamwork
PriyaVenkatesan
doi : 10.1016/S1474-4422(21)00209-X
Volume 20, Issue 11, November 2021, Page 889
Charles Dodgson and Alice in Wonderland syndrome
Jan DirkBlom
doi : 10.1016/S1474-4422(21)00338-0
Volume 20, Issue 11, November 2021, Pages 890-891
Esme Ekizoglu Turgut
doi : 10.1016/S1474-4422(21)00335-5
Volume 20, Issue 11, November 2021, Page 892
The retina as a window into the brain
Arpan RMehta
doi : 10.1016/S1474-4422(21)00332-X
Volume 20, Issue 11, November 2021, Page 892
Art speaks where words fail
RobertStirrups
doi : 10.1016/S1474-4422(21)00319-7
Volume 20, Issue 11, November 2021, Page 893
Sculpture and haptic deficit in the time of COVID-19
ColinMartin
doi : 10.1016/S1474-4422(21)00299-4
Volume 20, Issue 11, November 2021, Page 894
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
ProfPatrick GavinKehoePhDaNicholasTurnerPhDcdBethHowdenMSccdLinaJarutyteMScbShona LouiseCleggBScfhIan BrianMalonePhDfhJosephineBarnesPhDfhCasperNielsenPhDfhCarole HélèneSudrePhDijAileenWilsonDCReNgoc JadeThaiPhDeProfPeter SinclairBlairPhDcdElizabethCoulthardFRCPbProfJanet AtheneLanePhDcdProfPeterPassmoreMDkJodiTaylorPhDcdHenk-JanMutsaertsPhDlDavid LeeThomasPhDfhProfNick CharlesFoxFMedScifghProfIanWilkinsonFRCPmProfYoavBen-ShlomoPhDcdon behalf of the
doi : 10.1016/S1474-4422(21)00263-5
Volume 20, Issue 11, November 2021, Pages 895-906
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
Floris H B MSchreuderMDa*Koen Mvan NieuwenhuizenMDb*ProfJeannetteHofmeijerMDeSarah EVermeerMDeHenkKerkhoffMDfEllesZockPhDfGert-JanLuijckxMDgGert PMesschendorpMANPgJuliavan TuijlMDiH PaulBienfaitMDjSuzanne JBooijMDkIdo Rvan den WijngaardMDlmMichel J MRemmersMDnAntonia H C M LSchreuderMDoProfDiederik WDippelMDpJulieStaalsMDqPaul J A MBrouwersMDrMarieke J HWermerMDmJonathan MCoutinhoMDsVincent I HKwaMDtProfIsabelle Cvan GelderMDhProfRoger E GSchutgensMDcBerberZweedijkBScbProfAleAlgraMDbdJan Willemvan DalenPhDaProfLJaap KappelleMDbProfGabriel J ERinkelMDbProfH Bartvan der WorpMDb†ProfCatharina J MKlijnMDab†on behalf of theAPACHE-AF Trial Investigators‡
doi : 10.1016/S1474-4422(21)00298-2
Volume 20, Issue 11, November 2021, Pages 907-916
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
ProfAntonioUccelliMDacAliceLaroniMDacRehianaAliPhDdProfMario AlbertoBattagliaMDefMortenBlinkenbergMDgProfLouBrundinMDiProfMichelClanetMDjOscarFernandezMDkJamesMarriotMDlProfPaoloMuraroMDdProfSeyed MassoodNabaviMDmRoberto SOliveriMDhProfErnstRadueMDnCristinaRamo TelloMDoIreneSchiavettiPhDbProfJohannSellnerMDpqProfPer SoelbergSorensenMDgProfMaria PiaSormaniPhDbcJens ThomasWuerfelMDnProfMark SFreedmanMDrson behalf of the
doi : 10.1016/S1474-4422(21)00301-X
Volume 20, Issue 11, November 2021, Pages 917-929
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
JuanForteaMDabcShahid HZamanMDdeSiganHartleyPhDfMichael SRafiiMDgElizabethHeadPhDhMariaCarmona-IraguiMDabc
doi : 10.1016/S1474-4422(21)00245-3
Volume 20, Issue 11, November 2021, Pages 930-942
Neocortical development and epilepsy: insights from focal cortical dysplasia and brain tumours
ProfIngmarBlumckeMDaSilviaBuddayPhDbProfAnnapurnaPoduriMDcdDennisLalPhDeKatjaKobowPhDaStephanieBaulacPhDf
doi : 10.1016/S1474-4422(21)00265-9
Volume 20, Issue 11, November 2021, Pages 943-955
The role of manganese dysregulation in neurological disease: emerging evidence
DimitriBudingerMScaSerenaBarralPhDaAudrey K SSooMRCPCHabManju AKurianPhDab
doi : 10.1016/S1474-4422(21)00238-6
Volume 20, Issue 11, November 2021, Pages 956-968
